These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18066827)

  • 21. Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine.
    Sufrin JR; Spiess AJ; Kramer DL; Libby PR; Miller JT; Bernacki RJ; Lee YH; Borchardt RT; Porter CW
    J Med Chem; 1991 Aug; 34(8):2600-6. PubMed ID: 1908523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N
    Yu J; Zhao LX; Park J; Lee HW; Sahu PK; Cui M; Moss SM; Hammes E; Warnick E; Gao ZG; Noh M; Choi S; Ahn HC; Choi J; Jacobson KA; Jeong LS
    J Med Chem; 2017 Apr; 60(8):3422-3437. PubMed ID: 28380296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
    Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
    J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists.
    Devine SM; Gregg A; Figler H; McIntosh K; Urmaliya V; Linden J; Pouton CW; White PJ; Bottle SE; Scammells PJ
    Bioorg Med Chem; 2010 May; 18(9):3078-87. PubMed ID: 20385496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 2-chloro-N6-substituted-4'-thioadenosine-5'-N, N-dialkyluronamides as potent and selective A3 adenosine receptor antagonists.
    Choi WJ; Lee HW; Hou X; Kim HO; Jacobson KA; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):645-6. PubMed ID: 18776545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.
    Gao ZG; Joshi BV; Klutz AM; Kim SK; Lee HW; Kim HO; Jeong LS; Jacobson KA
    Bioorg Med Chem Lett; 2006 Feb; 16(3):596-601. PubMed ID: 16289820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and evaluation of 5'-S-aminoethyl-N(6)- azidobenzyl-5'-thioadenosine biotin conjugate: a bifunctional photoaffinity probe for the es nucleoside transporter.
    Addo JK; Buolamwini JK
    Bioconjug Chem; 2004; 15(3):536-40. PubMed ID: 15149181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 5'-nor aristeromycin analogues of 5'-deoxy-5'-methylthioadenosine and 5'-deoxy-5'-thiophenyladenosine.
    Das SR; Schneller SW
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(10):668-77. PubMed ID: 25222520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
    Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
    van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
    J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet aggregation inhibitors. IX. Chemical transformation of adenosine into 2-thioadenosine derivatives.
    Kikugawa K; Suehiro H; Yanase R; Aoki A
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):1959-69. PubMed ID: 922979
    [No Abstract]   [Full Text] [Related]  

  • 34. Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabine.
    Robins MJ; Peng Y; Damaraju VL; Mowles D; Barron G; Tackaberry T; Young JD; Cass CE
    J Med Chem; 2010 Aug; 53(16):6040-53. PubMed ID: 20718495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
    Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
    Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 3'-acetamidoadenosine derivatives as potential A3 adenosine receptor agonists.
    Chun MW; Choi SW; Kang TK; Choi WJ; Kim HO; Gao ZG; Jacobson KA; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2008 Apr; 27(4):408-20. PubMed ID: 18404574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topological descriptors in modeling the agonistic activity of human A3 adenosine receptor ligands: the derivatives of 2-chloro-N(6)-substituted-4'-thioadenosine-5'-uronamide.
    Sharma S; Sharma BK; Sharma SK; Singh P; Prabhakar YS
    Eur J Med Chem; 2009 Apr; 44(4):1377-82. PubMed ID: 18973967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells.
    Fossetta J; Jackson J; Deno G; Fan X; Du XK; Bober L; Soudé-Bermejo A; de Bouteiller O; Caux C; Lunn C; Lundell D; Palmer RK
    Mol Pharmacol; 2003 Feb; 63(2):342-50. PubMed ID: 12527805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-N,N-dialkyluronamides as human A3 adenosine receptor antagonists.
    Jeong LS; Lee HW; Kim HO; Tosh DK; Pal S; Choi WJ; Gao ZG; Patel AR; Williams W; Jacobson KA; Kim HD
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1612-6. PubMed ID: 18255292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Anticancer Res; 2006; 26(1A):43-7. PubMed ID: 16475677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.